{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:49:02Z","timestamp":1768315742381,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:p>Iron overload is a potential long-term complication among cancer survivors who received transfusions during treatment. Although there are screening guidelines for iron overload in pediatric survivors of hematopoietic stem cell transplant, these do not call for screening of other pediatric oncology patients. In our practice we incidentally discovered 3 patients in a population of 168 cancer survivors over the span of 17 years who were treated for cancer without hematopoietic stem cell transplant who had iron overload. The 3 patients had elevated liver iron on magnetic resonance imaging T2* and 2 received therapeutic phlebotomy. These cases, and others like them, suggest that collaborative groups should consider revisiting the literature to establish screening and treatment guidelines for iron overload after cancer therapy.<\/jats:p>","DOI":"10.1097\/mph.0000000000001064","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T20:31:10Z","timestamp":1515011470000},"page":"e164-e166","source":"Crossref","is-referenced-by-count":3,"title":["Incidentally Detected Transfusion-associated Iron Overload in 3 Children After Cancer Chemotherapy"],"prefix":"10.1097","volume":"40","author":[{"given":"Dennis John","family":"Kuo","sequence":"first","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, Rady Children\u2019s Hospital\u2014San Diego, University of California, San Diego, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Bhagia","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology-Oncology, St Joseph\u2019s Children\u2019s Hospital, Paterson, NJ"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2012.43.4951","article-title":"Yield of screening for long-term complications using the children\u2019s oncology group long-term follow-up guidelines","volume":"30","author":"Landier","year":"2012","journal-title":"J Clin Oncol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/pbc.22265","article-title":"Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children\u2019s Oncology Group","volume":"54","author":"Castellino","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbmt.2008.04.009","article-title":"High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors","volume":"14","author":"Majhail","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 2","key":"R4-20230918","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/S0268-960X(08)70004-3","article-title":"Cardiac iron across different transfusion-dependent diseases","volume":"22","author":"Wood","year":"2008","journal-title":"Blood Rev"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMct1004810","article-title":"Iron-chelating therapy for transfusional iron overload","volume":"364","author":"Brittenham","year":"2011","journal-title":"N Engl J Med"},{"key":"R7-20230918","first-page":"63","article-title":"Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation","volume":"17","author":"McKay","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/jmri.24584","article-title":"Quantification of liver iron with MRI: state of the art and remaining challenges","volume":"40","author":"Hernando","year":"2014","journal-title":"J Magn Reson Imaging"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13244-011-0132-1","article-title":"Quantification of iron concentration in the liver by MRI","volume":"3","author":"Al\u00fastiza Echeverr\u00eda","year":"2012","journal-title":"Insights Imaging"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/pbc.24629","article-title":"Risk factors for hyperferritinemia secondary to red blood cell transfusions in pediatric cancer patients","volume":"60","author":"Amid","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/pbc.25189","article-title":"Transfusion related iron overload in pediatric oncology patients treated at a tertiary care centre and treatment with chelation therapy","volume":"61","author":"Sait","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MPH.0000000000000444","article-title":"Iron overload in survivors of childhood cancer","volume":"38","author":"Schempp","year":"2016","journal-title":"J Pediatr Hematol Oncol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1158\/1055-9965.EPI-14-0292","article-title":"Characterization of transfusion-derived iron deposition in childhood cancer survivors","volume":"23","author":"Ruccione","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/pbc.24705","article-title":"Iron overload in children undergoing cancer treatments","volume":"60","author":"de Ville de Goyet","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1542\/peds.111.1.91","article-title":"Iron overload in children who are treated for acute lymphoblastic leukemia estimated by liver siderosis and serum iron parameters","volume":"111","author":"Halonen","year":"2003","journal-title":"Pediatrics"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/trf.12854","article-title":"Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload","volume":"55","author":"Panch","year":"2015","journal-title":"Transfusion"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T07:48:41Z","timestamp":1719733721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201804000-00029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001064","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]}}}